A vaccine targeting mutant IDH1 in newly diagnosed glioma
Nature, Published online: 24 March 2021; doi:10.1038/s41586-021-03363-z
A phase 1 clinical trial provides evidence that a vaccine against mutant IDH1 is safe and produces a T helper immune response in patients with glioma.
Comments
Post a Comment